FDA Recalls Weight Loss Drug Meridia—Act Now!
This October the Food and Drug Administration removed yet another risky weight loss drug from the market: Meridia, a popular anti-obesity medication from Abbott Laboratories. The FDA determined that the severe risks far outweighed the already minimal benefits after the publication of a damning study early in 2010 and years of warnings by safety advocates.
Study Links Meridia to Heart Attacks and Strokes
The study found that Meridia, also known by its generic name sibutramine, increased the risk of serious heart problems of 16 percent, heightening the likelihood for complications such as heart attacks, strokes, and even death. The study also found that taking Meridia resulted in only a small weight loss.
The FDA approved Meridia in 1997 to be prescribed for people struggling with obesity. Meridia is designed to block the re-uptake of certain brain chemicals called norepinephrine and serotonin. At the time, studies found that taking Meridia helped people lose at least 5 percent of their weight compared with people who took a placebo and relied on diet and exercise alone.
Stop Taking Meridia Immediately
It is estimated that about 100,000 Americans take Meridia. The FDA recommends that all currently on the medication should cease taking it immediately, and that doctors should stop prescribing it. The risk of heart disease should also end after a patient discontinues the medication.
The recall is reminiscent of the Fen-phen fiasco of the 1990s, when the earlier anti-obesity medication was shown to cause heart valve problems and pulmonary hypertension, both potentially fatal conditions. Though concerns about the drug’s safety surfaced within the manufacturing company in 1994, Wyeth did not withdraw their enormously popular drug until 1997.
For decades pharmaceutical manufacturers labored to develop effective drugs that would help people lose weight without risking dangerous side effects. Now that Meridia is no longer on the market, only two prescription weight loss drugs remain available: orlistat and phentermine. Doctors consider neither to be very effective.
Act Now—Contact Us Today
Seeger Weiss LLP is investigating injury claims associated with Meridia. If you or someone you know has taken Meridia and suffered adverse side effects, contact us today. An experienced attorney with Seeger Weiss LLP will assist you in evaluating your claim. Attorney consultations incur no obligation on your part and all initial consultations are free of charge. Seeger Weiss LLP has office locations in New York, New Jersey and Philadelphia.Free Case Evaluation
Seeger Weiss is investigating claims for a class action suit against Volkswagen and Audi related to a defective Timing Chain Tensioner System (“Tensioner System”) in all 2008 through 2013 model year vehicles [...]May 20, 2016 By: Seeger Weiss read more
OUR ROLE: Christopher A. Seeger, principal partner and co-founder of Seeger Weiss LLP, has been appointed to serve on the Plaintiffs’ Steering Committee, and as State Court Liaison Counsel, in the most [...]May 11, 2016 By: Seeger Weiss read more